Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK270822A is a selective ROCK1 inhibitor. GSK270822A exhibits IC50 of 9nM, 1100nM, 1550nM for ROCK1, RSK1, p70S6K, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 397.00 | |
5 mg | In stock | $ 970.00 | |
10 mg | In stock | $ 1,290.00 | |
25 mg | In stock | $ 1,950.00 | |
50 mg | In stock | $ 2,620.00 | |
100 mg | In stock | $ 3,530.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 995.00 |
Description | GSK270822A is a selective ROCK1 inhibitor. GSK270822A exhibits IC50 of 9nM, 1100nM, 1550nM for ROCK1, RSK1, p70S6K, respectively. |
In vitro | GSK270822A inhibits rat aortic ring dilation with IC50 of 76nM[1]. |
Synonyms | GSK 270822A, GSK-270822A |
Molecular Weight | 396.44 |
Formula | C24H20N4O2 |
CAS No. | 864082-23-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (126.12 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK270822A 864082-23-5 GPCR/G Protein GRK GSK 270822A GSK-270822A inhibitor inhibit